MaaT PharmaMaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors Original source on businesswire.comLanguage:EnglishFrançaisThis press release is being prepared.The market announcement is already indexed, but the document has not finished syncing to our storage yet.RefreshOpen original source